EF1a-HA-hM3D(Gq)-mCherry AAV (Serotype 9)

EF1a-HA-hM3D(Gq)-mCherry AAV (serotype 9) is a recombinant adeno-associated virus widely used in neuroscience and gene therapy research. AAV vectors are popular for their ability to safely and efficiently deliver genetic material into host cells. Among the various serotypes of AAV, serotype 9 is particularly known for its excellent ability to penetrate the blood-brain barrier, making it a valuable tool for neuronal targeting in vivo.

The EF1a promoter is a potent and ubiquitous promoter known for driving high levels of transgene expression in a variety of cell types, which is critical to ensure that the gene of interest is expressed in the target tissue. The HA tag provides a convenient detection and purification method due to its reactivity with HA-specific antibodies.

The hM3D(Gq) component refers to a specially designed G protein-coupled receptor (DREADD) that is designed to be activated by the otherwise pharmacologically inert compound clozapine nitro-oxide (CNO). This technology enables spatial and temporal control of neuronal activity, allowing researchers to manipulate cellular signaling pathways in vivo with high precision. Specifically, hM3D(Gq) is a modified human muscarinic receptor that upon activation stimulates intracellular signaling cascades through the Gq protein, typically leading to excitatory cellular responses. The construct also contains an mCherry fluorescent protein that acts as a versatile reporter gene. The bright red fluorescence emitted by mCherry allows researchers to visualize and confirm the expression and localization of the viral construct within host tissues.